JPRN-UMIN000018345已完成未知
Effects of canagliflozin on the glycemic control and plasma GLP-1 levels. - Effects of canagliflozin on the glycemic control and plasma GLP-1 levels.
akakinen clinic0 个研究点目标入组 45 人开始时间: 2015年8月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetes, diabetes due to a pancreatic disorder, or secondary diabetes due to conditions 2) Application of contraindications contained in the package insert 3) Severe renal function disorder 4)BMI is < 22kg/m2 5) Under treatment with insulin,GLP-1 analog, or SGLT2 inhibitor 6) Pregnant women, women suspected of being pregnant, or lactating women 7) Participation in the study is judged by the investigator or sub-investigator as inappropriate for any other reason
研究者
相似试验
已完成
不适用
Effect of canagliflozin for postprandial glucose controlType 2 diabetesJPRN-UMIN000030596St Marianna University School of Medicine15
招募中
不适用
Effect of Canagliflozin in Non-diabetic overweight and obesity Patients with albuminuria: A Randomized, Double-blind, Placebo-controlled TrialEffect of Canagliflozin in Non-diabetic overweight and obesity Patients.Canagliflozin and Non-diabetic overweight and obesity PatientsTCTR20190203003Rachadaphiseksompot Endorsement Fund80
已完成
不适用
Effect of canagliflozin in type 2 diabetic patients with microalbuminuria in Japanese populatioType 2 diabetes with microalbuminuriaJPRN-UMIN000029905Okayama University Hospital300
进行中（未招募）
不适用
Effect of canagliflozin in type 2 diabetic patients with microalbuminuria in Japanese populatioType 2 diabetes with microalbuminuriaJPRN-jRCTs061180047Miyamoto Satoshi110
已完成
1 期
A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT01381887Johnson & Johnson Pharmaceutical Research & Development, L.L.C.37